Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Tekla Healthcare Investors is an asset management business based in the US. Tekla Healthcare Investors shares (HQH) are listed on the NYSE and all prices are listed in US Dollars.
|Latest market close||USD$23.83|
|52-week range||USD$12.9179 - USD$23.91|
|50-day moving average||USD$22.2479|
|200-day moving average||USD$21.3218|
|Wall St. target price||N/A|
|Dividend yield||USD$1.92 (8.13%)|
|Earnings per share (TTM)||USD$5.498|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-01-14)||-0.17%|
|1 month (2020-12-24)||0.93%|
|3 months (2020-10-22)||15.18%|
|6 months (2020-07-22)||9.21%|
|1 year (2020-01-22)||11.67%|
|2 years (2019-01-22)||16.81%|
|3 years (2018-01-22)||24.1|
|5 years (2016-01-22)||25.45|
Valuing Tekla Healthcare Investors stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Tekla Healthcare Investors's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Tekla Healthcare Investors's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 4x. In other words, Tekla Healthcare Investors shares trade at around 4x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
|Revenue TTM||USD$8.9 million|
|Gross profit TTM||USD$8.9 million|
|Return on assets TTM||-0.13%|
|Return on equity TTM||25.05%|
|Market capitalisation||USD$1 billion|
TTM: trailing 12 months
There are currently 91,926 Tekla Healthcare Investors shares held short by investors – that's known as Tekla Healthcare Investors's "short interest". This figure is 6.4% up from 86,365 last month.
There are a few different ways that this level of interest in shorting Tekla Healthcare Investors shares can be evaluated.
Tekla Healthcare Investors's "short interest ratio" (SIR) is the quantity of Tekla Healthcare Investors shares currently shorted divided by the average quantity of Tekla Healthcare Investors shares traded daily (recently around 148267.74193548). Tekla Healthcare Investors's SIR currently stands at 0.62. In other words for every 100,000 Tekla Healthcare Investors shares traded daily on the market, roughly 620 shares are currently held short.
However Tekla Healthcare Investors's short interest can also be evaluated against the total number of Tekla Healthcare Investors shares, or, against the total number of tradable Tekla Healthcare Investors shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Tekla Healthcare Investors's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Tekla Healthcare Investors shares in existence, roughly 0 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable Tekla Healthcare Investors shares, roughly 0 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Tekla Healthcare Investors.
Find out more about how you can short Tekla Healthcare Investors stock.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Tekla Healthcare Investors.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 29.97
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Tekla Healthcare Investors's overall score of 29.97 (as at 01/01/2019) is excellent – landing it in it in the 6th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Tekla Healthcare Investors is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 3.07/100
Tekla Healthcare Investors's environmental score of 3.07 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Tekla Healthcare Investors is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 17.72/100
Tekla Healthcare Investors's social score of 17.72 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Tekla Healthcare Investors is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 9.07/100
Tekla Healthcare Investors's governance score puts it squarely in the 6th percentile of companies rated in the same sector. That could suggest that Tekla Healthcare Investors is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
|Total ESG score||29.97|
|Total ESG percentile||6|
|Environmental score percentile||6|
|Social score percentile||6|
|Governance score percentile||6|
Dividend payout ratio: 28.83% of net profits
Recently Tekla Healthcare Investors has paid out, on average, around 28.83% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 8.13% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Tekla Healthcare Investors shareholders could enjoy a 8.13% return on their shares, in the form of dividend payments. In Tekla Healthcare Investors's case, that would currently equate to about $1.92 per share.
While Tekla Healthcare Investors's payout ratio might seem fairly standard, it's worth remembering that Tekla Healthcare Investors may be investing much of the rest of its net profits in future growth.
Tekla Healthcare Investors's most recent dividend payout was on 31 December 2018. The latest dividend was paid out to all shareholders who bought their shares by 30 December 2020 (the "ex-dividend date").
Over the last 12 months, Tekla Healthcare Investors's shares have ranged in value from as little as $12.9179 up to $23.91. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Tekla Healthcare Investors's is 1.0887. This would suggest that Tekla Healthcare Investors's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. It was previously known as H&Q Healthcare Investors. Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.
Steps to owning and managing SSNC, with 24-hour and historical pricing before you buy.
Steps to owning and managing SMBC, with 24-hour and historical pricing before you buy.
Steps to owning and managing SMED, with 24-hour and historical pricing before you buy.
Steps to owning and managing SJW, with 24-hour and historical pricing before you buy.
Steps to owning and managing SFBS, with 24-hour and historical pricing before you buy.
Steps to owning and managing LEDS, with 24-hour and historical pricing before you buy.
Steps to owning and managing SC, with 24-hour and historical pricing before you buy.
Steps to owning and managing RTW, with 24-hour and historical pricing before you buy.
Steps to owning and managing RIVE, with 24-hour and historical pricing before you buy.
Steps to owning and managing RVSB, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.